Could your gut bacteria trigger kidney disease? new study investigates

NCT ID NCT04924712

Recruiting now Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examines 30 adults with idiopathic nephrotic syndrome, a kidney condition that can lead to kidney failure. Researchers will analyze blood immune cells and bacteria from stool and urine samples to see if changes in gut or urinary bacteria are linked to immune system problems. The goal is to better understand what causes the disease, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could point toward new ways to treat or manage idiopathic nephrotic syndrome by targeting the immune system or gut bacteria.
What could go wrong: This is a small observational study (30 people) that only measures differences, not treatments. It may not find clear links or lead to direct therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-LYMPHOCYTES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

focal segmental glomerulosclerosis glomerulosclerosis idiopathic nephrotic syndrome lipoid nephrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

B-LYMPHOCYTES GLOMERULOSCLEROSIS MICROBIOTA T-LYMPHOCYTES

Contacts and locations

Locations

Departemental Hospital Center
RECRUITING

La Roche-sur-Yon, 85925, France
Nantes University Hospital
RECRUITING

Nantes, Loire-Atlantique, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.